Key result
Anti-cancer treatments and active cancer predispose patients to acute coronary syndrome through mechanisms including accelerated atherosclerosis, thrombosis, and vasospasm.
Why the study?
Cardiovascular diseases and cancer increasingly coexist, and anti-cancer treatment can damage cardiovascular components and lead to acute coronary syndrome.
This review summarizes the pathophysiology, clinical presentation, and diagnosis of acute coronary syndrome in patients with cancer.
Alerts clinicians to ACS risk during cancer therapy; leaves open optimal integrated management strategies.
Coexistence of cardiovascular diseases and cancer is more and more common in everyday practice. This is due to the aging of the population and the fact that most of the classic cardiovascular risk factors also predispose to cancer. During anti-cancer treatment, cardiovascular components may be damaged and eventually lead to acute coronary syndrome. The first part of the review article presents the pathophysiology, clinical presentation and key elements of the diagnostic process of this life-threatening condition in cancer patients.
No takes yet. Share an insight, caveat, or question.
Grzegorz Piotrowski (2020) conducted a review in Acute coronary syndrome in cancer patients. Anti-cancer treatment was evaluated. Anti-cancer treatments and active cancer predispose patients to acute coronary syndrome through mechanisms including accelerated atherosclerosis, thrombosis, and vasospasm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: